Trial Information
Video Images of Disease for Ethical Outcomes
Inclusion Criteria:
- Age 65 or older Patient does not have the capacity to make decisions Patient admitted to
the ICU with life threatening illness including advanced heart, renal, lung,
gastrointestinal and oncologic disease Patient has English speaking representative to make
decisions on his/her behalf Patient critically ill and unlikely to survive to hospital
discharge
Exclusion Criteria:
- Patients who are imminently dying and admitted to the ICU are excluded Wards if the
state
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
preference for goal of care regarding medical interventions (e.g., CPR, intubation, etc.)
Outcome Time Frame:
at baseline admission to the ICU during family meeting up to one week
Safety Issue:
No
Principal Investigator
Angelo Volandes
Investigator Role:
Principal Investigator
Investigator Affiliation:
MGH
Authority:
United States: Food and Drug Administration
Study ID:
2010-P-001820
NCT ID:
NCT01776333
Start Date:
January 2013
Completion Date:
Related Keywords:
- Admission to the ICU With Life-threatening Advanced Illness Including Advanced Heart Disease, Kidney Disease, Lung Disease, Gastrointestinal Disease and Cancer.
- ICU
- Digestive System Diseases
- Gastrointestinal Diseases
- Heart Diseases
- Kidney Diseases
- Lung Diseases
Name | Location |
Cedars Sinai Medical Center |
Los Angeles, California 90048-1804 |
MGH |
Boston, Massachusetts 02114 |
BMC |
Boston, Massachusetts |